Parkwalk

Parkwalk, Boehringer Ingelheim Venture Fund (BIVF) and Oxford University Innovation Fund
By  Anna Engberg 01:51 am December 23, 2021
The British medtech company Brainomix has announced that it has closed a series B funding round with a total investment of approximately £16 million. The previous investors Parkwalk, Boehringer Ingelheim Venture Fund (BIVF) and Oxford University Innovation Fund (OUIF), who are participating again in this round, have been joined by Tencent Holdings. WHY IT MATTERS Brainomix recently took the ...